$3.520
+1.052 (+29.89%)Al cierre
Rentabilidad y márgenes de WGRX
Evaluating the bottom line, DataMeds AI Inc maintains a gross margin of -11.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -385.72%, while the net margin is -496.46%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively WGRX converts its operational activities into shareholder value.
Comparativa sectorial de WGRX
In the context of the broader market, WGRX competes directly with industry leaders such as JWEL and POM. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, WGRX's gross margin of -11.97% stands against JWEL's 8.16% and POM's 13.07%. Such benchmarking helps identify whether DataMeds AI Inc is trading at a premium or discount relative to its financial performance.
Desempeño financiero de Wellgistics Health Inc
No financial data available for analysis.
Financials
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.